Extractables and Leachables Testing Market Insights, Competitive Landscape, and Market Forecast

Description

Introduction

Extractables and leachables testing identifies chemical compounds that can migrate from packaging, manufacturing equipment and medical devices into drug products or patients. Extractables are substances that can be drawn out of a material under aggressive laboratory conditions, while leachables are those that actually enter a product during normal storage or use. Because even trace amounts of some compounds can affect product quality or patient safety, regulators require manufacturers to evaluate these risks carefully. In 2026, the market is valued at US$1.35 Bn and is projected to reach US$3.57 Bn by 2033, registering a CAGR of 14.90%. Growth is being driven by new and harmonised regulatory guidance, the rapid expansion of biologics, wider use of single-use manufacturing systems and the rise of complex combination products that pair drugs with delivery devices. The discipline itself is changing, moving away from exhaustive testing of everything toward risk-based study design, supported by toxicological risk assessment and closer scrutiny of the components used throughout the manufacturing process.

Market Insights

The market is segmented by product type, application and end user. Product types include container closure systems, single-use systems, drug delivery devices and manufacturing components. Single-use systems are the fastest-growing product type, expanding at a 17.6% CAGR, as biopharmaceutical manufacturers adopt disposable bags, tubing and connectors that must be assessed for potential contaminants. Applications cover orally inhaled and nasal drug products, parenteral drug products, ophthalmic drug products, and oral and transdermal products. Parenteral products are the fastest-growing application at 16.8%, reflecting the growth of injectable biologics where patient exposure risk is high. End users include pharmaceutical and biopharmaceutical companies, medical device manufacturers and others, with device makers the fastest-growing end user at 16.2% as regulatory expectations for devices tighten. The market is shifting toward risk-based study design, in which testing effort is matched to the actual likelihood and impact of exposure. Toxicological risk assessment is becoming central to interpreting results, and manufacturing components are receiving greater attention alongside final packaging.

Drivers

Two high-impact drivers shape demand. The first is new and harmonised regulatory guidance. Regulators are aligning expectations for how extractables and leachables should be studied and evaluated, and new guidance is raising the bar for documentation, analytical methods and safety assessment. Manufacturers preparing submissions for new products, or updating existing ones, must commission more comprehensive studies to demonstrate compliance across markets. The second driver is the growth of biologics, single-use systems and combination products. Biologic drugs are sensitive to impurities, single-use equipment introduces many plastic contact surfaces into production, and combination products bring device materials into direct contact with drugs. Each of these trends increases the number and complexity of studies required. These drivers face restraints. High testing costs and long study timelines form a high-impact restraint, since comprehensive studies can be expensive and slow product development. A shortage of skilled analysts and toxicologists represents a medium-impact restraint, limiting laboratory capacity and lengthening turnaround times when demand rises sharply.

Business Opportunity

Risk-based testing under the ICH Q3E guideline represents a consulting revenue pool with strong potential. The guidance encourages manufacturers to design studies based on a structured assessment of risk rather than applying uniform testing to every material. Many companies need help interpreting these expectations, building risk assessments, selecting appropriate analytical approaches and justifying their strategies to regulators. Service providers that combine analytical laboratories with regulatory and toxicological expertise can offer end-to-end support, moving beyond routine testing into higher-value advisory work. A second opportunity lies in medical devices and emerging markets as a growth revenue pool. Device manufacturers face increasingly rigorous requirements to characterise materials that contact patients, and they are the fastest-growing end user group. At the same time, pharmaceutical production is expanding across emerging economies, where manufacturers seeking to export must meet international standards for extractables and leachables. Laboratories that establish local capacity, build device expertise and offer harmonised global study packages are well placed to capture this rising demand.

Region Analysis

North America leads the market with a 37.6% share in 2026. The region hosts a large concentration of pharmaceutical, biotechnology and medical device companies, extensive biologics development and manufacturing, and a regulatory environment with well-established expectations for extractables and leachables data. Many specialised testing laboratories and consulting providers are also based there. Europe is a major market, supported by a strong pharmaceutical and device industry, rigorous regulatory oversight and growing use of single-use systems in biologics production. Asia Pacific is the fastest-growing region, expanding at an 18.1% CAGR through 2033, as contract manufacturing, biologics and biosimilar production, and medical device exports grow rapidly across major economies, requiring studies that satisfy international regulators. Latin America is developing steadily, with demand tied to local pharmaceutical manufacturing and efforts to align with global quality standards. The Middle East and Africa is an emerging market, where investment in domestic pharmaceutical production and stronger regulatory frameworks are gradually creating demand for testing services.

Key Players

Eurofins Scientific
SGS
Intertek
Sotera Health (Nelson Labs)
WuXi AppTec
West Pharmaceutical Services
Merck KGaA
Pacific BioLabs
Boston Analytical
Medical Engineering Technologies

Segmentation

By Product Type:

Container Closure Systems
Single-use Systems
Drug Delivery Devices
Manufacturing Components

By Application:

Orally Inhaled and Nasal Drug Products
Parenteral Drug Products
Ophthalmic Drug Products
Oral & Transdermal Products

By End User:

Pharmaceutical & Biopharmaceutical Companies
Medical Device Manufacturers
Others

By Geographic Coverage:

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

1. Executive Summary

1.1. Global Extractables and Leachables Testing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors

3. Global Extractables and Leachables Testing Market Outlook, 2020 - 2033

3.1. Global Extractables and Leachables Testing Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 3.1.1. Container Closure Systems
- 3.1.2. Single-use Systems
- 3.1.3. Drug Delivery Devices
- 3.1.4. Manufacturing Components
3.2. Global Extractables and Leachables Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 3.2.1. Orally Inhaled and Nasal Drug Products
- 3.2.2. Parenteral Drug Products
- 3.2.3. Ophthalmic Drug Products
- 3.2.4. Oral & Transdermal Products
3.3. Global Extractables and Leachables Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 3.3.1. Pharmaceutical & Biopharmaceutical Companies
- 3.3.2. Medical Device Manufacturers
- 3.3.3. Others
3.4. Global Extractables and Leachables Testing Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.4.1. North America
- 3.4.2. Europe
- 3.4.3. Asia Pacific
- 3.4.4. Latin America
- 3.4.5. Middle East & Africa

4. North America Extractables and Leachables Testing Market Outlook, 2020 - 2033

4.1. North America Extractables and Leachables Testing Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 4.1.1. Container Closure Systems
- 4.1.2. Single-use Systems
- 4.1.3. Drug Delivery Devices
- 4.1.4. Manufacturing Components
4.2. North America Extractables and Leachables Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 4.2.1. Orally Inhaled and Nasal Drug Products
- 4.2.2. Parenteral Drug Products
- 4.2.3. Ophthalmic Drug Products
- 4.2.4. Oral & Transdermal Products
4.3. North America Extractables and Leachables Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 4.3.1. Pharmaceutical & Biopharmaceutical Companies
- 4.3.2. Medical Device Manufacturers
- 4.3.3. Others
4.4. North America Extractables and Leachables Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.4.1. U.S. Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 4.4.2. U.S. Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 4.4.3. U.S. Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 4.4.4. Canada Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 4.4.5. Canada Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 4.4.6. Canada Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Extractables and Leachables Testing Market Outlook, 2020 - 2033

5.1. Europe Extractables and Leachables Testing Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 5.1.1. Container Closure Systems
- 5.1.2. Single-use Systems
- 5.1.3. Drug Delivery Devices
- 5.1.4. Manufacturing Components
5.2. Europe Extractables and Leachables Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 5.2.1. Orally Inhaled and Nasal Drug Products
- 5.2.2. Parenteral Drug Products
- 5.2.3. Ophthalmic Drug Products
- 5.2.4. Oral & Transdermal Products
5.3. Europe Extractables and Leachables Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 5.3.1. Pharmaceutical & Biopharmaceutical Companies
- 5.3.2. Medical Device Manufacturers
- 5.3.3. Others
5.4. Europe Extractables and Leachables Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.4.1. Germany Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 5.4.2. Germany Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 5.4.3. Germany Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 5.4.4. Italy Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 5.4.5. Italy Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 5.4.6. Italy Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 5.4.7. France Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 5.4.8. France Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 5.4.9. France Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 5.4.10. U.K. Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 5.4.11. U.K. Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 5.4.12. U.K. Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 5.4.13. Spain Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 5.4.14. Spain Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 5.4.15. Spain Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 5.4.16. Russia Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 5.4.17. Russia Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 5.4.18. Russia Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 5.4.19. Rest of Europe Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 5.4.20. Rest of Europe Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 5.4.21. Rest of Europe Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Extractables and Leachables Testing Market Outlook, 2020 - 2033

6.1. Asia Pacific Extractables and Leachables Testing Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 6.1.1. Container Closure Systems
- 6.1.2. Single-use Systems
- 6.1.3. Drug Delivery Devices
- 6.1.4. Manufacturing Components
6.2. Asia Pacific Extractables and Leachables Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 6.2.1. Orally Inhaled and Nasal Drug Products
- 6.2.2. Parenteral Drug Products
- 6.2.3. Ophthalmic Drug Products
- 6.2.4. Oral & Transdermal Products
6.3. Asia Pacific Extractables and Leachables Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 6.3.1. Pharmaceutical & Biopharmaceutical Companies
- 6.3.2. Medical Device Manufacturers
- 6.3.3. Others
6.4. Asia Pacific Extractables and Leachables Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.4.1. China Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 6.4.2. China Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 6.4.3. China Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 6.4.4. Japan Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 6.4.5. Japan Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 6.4.6. Japan Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 6.4.7. South Korea Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 6.4.8. South Korea Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 6.4.9. South Korea Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 6.4.10. India Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 6.4.11. India Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 6.4.12. India Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 6.4.13. Southeast Asia Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 6.4.14. Southeast Asia Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 6.4.15. Southeast Asia Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 6.4.16. Rest of SAO Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 6.4.17. Rest of SAO Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 6.4.18. Rest of SAO Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Extractables and Leachables Testing Market Outlook, 2020 - 2033

7.1. Latin America Extractables and Leachables Testing Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 7.1.1. Container Closure Systems
- 7.1.2. Single-use Systems
- 7.1.3. Drug Delivery Devices
- 7.1.4. Manufacturing Components
7.2. Latin America Extractables and Leachables Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 7.2.1. Orally Inhaled and Nasal Drug Products
- 7.2.2. Parenteral Drug Products
- 7.2.3. Ophthalmic Drug Products
- 7.2.4. Oral & Transdermal Products
7.3. Latin America Extractables and Leachables Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 7.3.1. Pharmaceutical & Biopharmaceutical Companies
- 7.3.2. Medical Device Manufacturers
- 7.3.3. Others
7.4. Latin America Extractables and Leachables Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.4.1. Brazil Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 7.4.2. Brazil Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 7.4.3. Brazil Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 7.4.4. Mexico Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 7.4.5. Mexico Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 7.4.6. Mexico Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 7.4.7. Argentina Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 7.4.8. Argentina Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 7.4.9. Argentina Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 7.4.10. Rest of LATAM Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 7.4.11. Rest of LATAM Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 7.4.12. Rest of LATAM Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Extractables and Leachables Testing Market Outlook, 2020 - 2033

8.1. Middle East & Africa Extractables and Leachables Testing Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 8.1.1. Container Closure Systems
- 8.1.2. Single-use Systems
- 8.1.3. Drug Delivery Devices
- 8.1.4. Manufacturing Components
8.2. Middle East & Africa Extractables and Leachables Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 8.2.1. Orally Inhaled and Nasal Drug Products
- 8.2.2. Parenteral Drug Products
- 8.2.3. Ophthalmic Drug Products
- 8.2.4. Oral & Transdermal Products
8.3. Middle East & Africa Extractables and Leachables Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 8.3.1. Pharmaceutical & Biopharmaceutical Companies
- 8.3.2. Medical Device Manufacturers
- 8.3.3. Others
8.4. Middle East & Africa Extractables and Leachables Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.4.1. GCC Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 8.4.2. GCC Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 8.4.3. GCC Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 8.4.4. South Africa Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 8.4.5. South Africa Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 8.4.6. South Africa Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 8.4.7. Egypt Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 8.4.8. Egypt Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 8.4.9. Egypt Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 8.4.10. Nigeria Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 8.4.11. Nigeria Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 8.4.12. Nigeria Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
- 8.4.13. Rest of Middle East Extractables and Leachables Testing Market Outlook, by Product Type, 2020-2033
- 8.4.14. Rest of Middle East Extractables and Leachables Testing Market Outlook, by Application, 2020-2033
- 8.4.15. Rest of Middle East Extractables and Leachables Testing Market Outlook, by End User, 2020-2033
8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Eurofins Scientific
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Developments
- 9.4.2. SGS
- 9.4.3. Intertek
- 9.4.4. Sotera Health (Nelson Labs)
- 9.4.5. WuXi AppTec
- 9.4.6. West Pharmaceutical Services
- 9.4.7. Merck KGaA
- 9.4.8. Pacific BioLabs
- 9.4.9. Boston Analytical
- 9.4.10. Medical Engineering Technologies

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Extractables and Leachables Testing Market Insights, Competitive Landscape, and Market Forecast - 2033